- Home
- VCEL vs QDEL Comparison
VCEL vs QDEL Comparison
Compare VCEL & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- QDEL
- Stock Information
- Founded
- VCEL 1989
- QDEL 1979
- Country
- VCEL United States
- QDEL United States
- Employees
- VCEL N/A
- QDEL N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- QDEL Medical Specialities
- Sector
- VCEL Health Care
- QDEL Health Care
- Exchange
- VCEL Nasdaq
- QDEL Nasdaq
- Market Cap
- VCEL 1.8B
- QDEL 1.9B
- IPO Year
- VCEL 1997
- QDEL N/A
- Fundamental
- Price
- VCEL $36.28
- QDEL $27.13
- Analyst Decision
- VCEL Strong Buy
- QDEL Hold
- Analyst Count
- VCEL 6
- QDEL 6
- Target Price
- VCEL $58.60
- QDEL $39.00
- AVG Volume (30 Days)
- VCEL 563.8K
- QDEL 1.1M
- Earning Date
- VCEL 11-06-2025
- QDEL 11-05-2025
- Dividend Yield
- VCEL N/A
- QDEL N/A
- EPS Growth
- VCEL 2045.40
- QDEL N/A
- EPS
- VCEL 0.13
- QDEL N/A
- Revenue
- VCEL $249,119,000.00
- QDEL $2,741,600,000.00
- Revenue This Year
- VCEL $18.35
- QDEL N/A
- Revenue Next Year
- VCEL $22.26
- QDEL $2.65
- P/E Ratio
- VCEL $272.85
- QDEL N/A
- Revenue Growth
- VCEL 16.13
- QDEL N/A
- 52 Week Low
- VCEL $29.24
- QDEL $22.05
- 52 Week High
- VCEL $63.00
- QDEL $49.45
- Technical
- Relative Strength Index (RSI)
- VCEL 56.70
- QDEL 45.13
- Support Level
- VCEL $33.76
- QDEL $26.17
- Resistance Level
- VCEL $37.00
- QDEL $30.85
- Average True Range (ATR)
- VCEL 1.48
- QDEL 1.23
- MACD
- VCEL 0.05
- QDEL -0.21
- Stochastic Oscillator
- VCEL 81.35
- QDEL 25.21
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.